John Abrams of the University of Texas Southwestern Medical Center in the U.S. will utilize novel mutagenesis and selection strategies to develop new variants of the Cry protein, a toxin producing the pathogen Bt, in an effort to create customized insecticides that can selectively target disease vectors without harming humans and non-target species.
Grant ID
OPP53134
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False